Alpine Woods Capital Investors, LLC Neurocrine Biosciences Inc Transaction History

Alpine Woods Capital Investors, LLC

  • $626 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$86.18 - $99.03 $233,547 - $268,371
-2,710 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$89.43 - $102.27 $250,404 - $286,356
-2,800 Reduced 50.82%
2,710 $264,000
Q1 2021

May 11, 2021
SELL
$87.57 - $119.4 $237,314 - $323,574
-2,710 Reduced 32.97%
5,510 $536,000
Q4 2020

Feb 01, 2021
BUY
$86.91 - $108.33 $714,400 - $890,472
8,220 New
8,220 $788,000

Others Institutions Holding NBIX

# of Institutions
627
Shares Held
94M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Alpine Woods Capital Investors, LLC Portfolio

Follow Alpine Woods Capital Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email